Salf Sodium Chloride 0.9% 5 Vials Of 2ml

Salf Sodium Chloride 0.9% 5 Vials Of 2ml
Regular Price €3.50 Special Price €3.17
-9% Save: €0.33
In stock
icomoon-up
icomoon-down
Manufacturer
SALF
SKU
030684664
Active principle
SODIO CLORURO
NAME
SODIUM CHLORIDE SALF 0.9% SOLVENT FOR PARENTERAL USE

PHARMACOTHERAPEUTIC CATEGORY
Solvents and thinners.

ACTIVE PRINCIPLES
Sodium chloride.

EXCIPIENTS
Water for injections.

INDICATIONS
Preparation of injectable preparations.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypernatremia; hydrosaline plethora.

DOSAGE
Use for extemporaneous solutions, dilutions or suspensions of injectable medicaments or other sterile preparations. Choose the volume to be used based on the dilution needs of the injectable preparation.

STORAGE
Store in tightly closed container. Do not freeze or refrigerate.

WARNINGS
Sodium salts should be administered with caution in patients with hypertension, heart failure, peripheral or pulmonary edema, impaired renal function, pre-eclampsia, or other conditions associated with sodium retention. The solution should be clear, colorless and free from visible particles. Use immediately after opening the container and make sure that the preparation takes place in the shortest time possible under conditions and according to procedures that preserve the sterility of the solution as much as possible. Any remaining unused medicine should be discarded.

INTERACTIONS
Corticosteroids are associated with sodium and water retention, resulting in edema and hypertension: therefore, caution should be exercised in the simultaneous administration of sodium salts and corticosteroids. Although sodium chloride is compatible with a large number of medicines, please refer to the SmPC relating to the medicine you intend to administer, in order to verify its compatibility.

SIDE EFFECTS
Undesirable effects following administration of sodium chloride mainly refer to disorders of water and electrolyte balance (hypernatremia, hyperchloraemia, hypervolemia) and problems related to the administration site (infusion site infection, pain or local reaction, venous irritation, thrombosis or phlebitis-venous extending from the infusion site, extravasation).

PREGNANCY AND BREASTFEEDING
Although no effects on the development of the fetus have been highlighted, the drug should be administered only in case of real need and only after evaluating the risk / benefit ratio. The medicine is compatible with breastfeeding.